Evaluation of Cumulative Prognostic Scores Based on the Systemic Inflammatory Response in Patients with Inoperable Non-small-cell Lung Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 2003 Sep 11

PMID 12966420

Citations 361

Authors

L M Forrest

D C McMillan

C S McArdle

W J Angerson

D J Dunlop

Affiliations

Soon will be listed here.

Abstract

A score based on the combination of the systemic inflammatory response and albumin hazards ratio (HR) 1.70, 95% CI 1.23 - 2.35, P=0.001) was comparable in prognostic value to that based on stage and performance status (HR 1.48, 95% CI 1.12 - 1.95, P=0.006) in patients with inoperable non-small-cell lung cancer. The former is simple to measure and well standardised.

Citing Articles

Association between stroke and systemic inflammation response index (SIRI): a National Health and Nutrition Examination Survey (NHANES) Study 2015-2020.

Valibeygi A, Fardaei M, Niknejad S BMJ Neurol Open. 2025; 7(1):e000718.

PMID: 40041612 PMC: 11877209. DOI: 10.1136/bmjno-2024-000718.

Effect of Nutritional Index on Lenvatinib Treatment Retention Rates in Unresectable Hepatocellular Carcinoma.

Wakamatsu R, Nakayama M, Wakamatsu A, Yamashita Y, Suto H, Katsuragawa M In Vivo. 2025; 39(2):988-999.

PMID: 40010999 PMC: 11884448. DOI: 10.21873/invivo.13904.

Baseline (modified) Glasgow prognostic score as a predictor of therapeutic response to immune checkpoint inhibitors in solid tumors: A systematic review and meta‑analysis.

Ye H, Li M Oncol Lett. 2025; 29(4):184.

PMID: 40007624 PMC: 11851447. DOI: 10.3892/ol.2025.14931.

Preoperative occult vertebral fracture is a stronger predictor than osteopenia of the clinical outcomes after gastrectomy for gastric cancer.

Fukushima N, Masuda T, Furukawa K, Tsuboi K, Takahashi K, Yuda M Oncol Lett. 2025; 29(4):179.

PMID: 39990809 PMC: 11843434. DOI: 10.3892/ol.2025.14925.

Association of inflammatory risk based on the Glasgow Prognostic Score with long-term mortality in patients with cardiovascular disease.

Zhu H, Yang C, Liu X, Zhu X, Xu X, Wang H Sci Rep. 2025; 15(1):6474.

PMID: 39987233 PMC: 11846972. DOI: 10.1038/s41598-025-90238-2.

References

Arias-Diaz J, Vara E, Torres-Melero J, Garcia C, Baki W, Ramirez-Armengol J . Nitrite/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients. Cancer. 1994; 74(5):1546-51. DOI: 10.1002/1097-0142(19940901)74:5<1546::aid-cncr2820740509>3.0.co;2-f. View

Mountain C . A new international staging system for lung cancer. Chest. 1986; 89(4 Suppl):225S-233S. DOI: 10.1378/chest.89.4_supplement.225s. View

Herndon 2nd J, Fleishman S, Kornblith A, Kosty M, Green M, Holland J . Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?. Cancer. 1999; 85(2):333-40. DOI: 10.1002/(sici)1097-0142(19990115)85:2<333::aid-cncr10>3.0.co;2-q. View

Mahmoud F, Rivera N . The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep. 2002; 4(3):250-5. DOI: 10.1007/s11912-002-0023-1. View

Martin F, Santolaria F, Batista N, Milena A, Gonzalez-Reimers E, Brito M . Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine. 1999; 11(1):80-6. DOI: 10.1006/cyto.1998.0398. View

Numico G, Russi E, Merlano M . Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?. Lung Cancer. 2001; 32(3):213-26. DOI: 10.1016/s0169-5002(00)00222-1. View

Scott H, McMillan D, Crilly A, McArdle C, Milroy R . The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer. 1996; 73(12):1560-2. PMC: 2074552. DOI: 10.1038/bjc.1996.294. View

Paesmans M, Sculier J, Libert P, Bureau G, Dabouis G, Thiriaux J . Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party. Eur J Cancer. 1998; 33(14):2326-32. DOI: 10.1016/s0959-8049(97)00325-0. View

Dentener M, Schols A, Buurman W, Wouters E . Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol. 1995; 13(10):2600-5. DOI: 10.1200/JCO.1995.13.10.2600. View

10.

McMillan D, Scott H, Watson W, Preston T, Milroy R, McArdle C . Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer. 1998; 31(2):101-5. DOI: 10.1080/01635589809514687. View

11.

Simons J, Schols A, Buurman W, Wouters E . Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond). 1999; 97(2):215-23. View

12.

Yanagawa H, Sone S, Takahashi Y, Haku T, Yano S, Shinohara T . Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer. 1995; 71(5):1095-8. PMC: 2033769. DOI: 10.1038/bjc.1995.212. View

13.

Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K . Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer. 2001; 85(11):1634-9. PMC: 2363970. DOI: 10.1054/bjoc.2001.2162. View

14.

Scott H, McMillan D, Brown D, Forrest L, McArdle C, Milroy R . A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer. 2003; 40(3):295-9. DOI: 10.1016/s0169-5002(03)00077-1. View

15.

Scott H, McMillan D, Forrest L, Brown D, McArdle C, Milroy R . The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer. 2002; 87(3):264-7. PMC: 2364225. DOI: 10.1038/sj.bjc.6600466. View

16.

OGorman P, McMillan D, McArdle C . Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer. 2000; 37(1):36-40. DOI: 10.1207/S15327914NC3701_4. View